Life Technologies' Applied Biosystems ViiA 7 real-time PCR system is designed for a variety of quantitative PCR (qPCR) and genotyping applications.
The system has been designed to improve researcher productivity for research
that includes how gene expression changes in response to pharmacological
agents, and how genetic variation influences response to treatments for
disease. The system simplifies real-time PCR applications; all integrated
and accessible from a touch screen. The system provides the sensitivity to
detect a single copy of starting genetic material and offers enhanced
The system's software integrates standard real-time PCR applications like
nucleic acid quantification, detection of single nucleotide polymorphisms
(SNPs), and copy number variation detection with others that include
high-resolution melting, protein analysis with proximity ligation
technology, and gene expression analysis performed directly from cultured
cells without RNA purification.
The system includes usability enhancements that enable efficient and
cost-effective research. Through one-touch protocols, researchers can
operate the system without a separate computer and monitor runs from remote
locations. Automated sample loading enables uninterrupted system operation
and eliminates the need for robotic pipetting equipment.
Life Technologies is a global biotechnology tools company dedicated to
improving the human condition. The company's systems, consumables and
services enable researchers to accelerate scientific exploration, driving to
discoveries and developments that make life even better. Life Technologies
customers do their work across the biological spectrum, working to advance
personalized medicine, regenerative science, molecular diagnostics,
agricultural and environmental research, and 21st century forensics. The
company has historical sales of approximately $3.5 billion, employs 9,500
people, has a presence in more than 100 countries, and possesses a rapidly
growing intellectual property estate of over 3,600 patents and exclusive
licenses. Life Technologies was created by the combination of Invitrogen
Corporation and Applied Biosystems Inc.